Chemed Corporation (CHE)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 604.17 |
| Open | 604.08 |
| Bid | 597.78 x 900 |
| Ask | 599.71 x 800 |
| Day's range | 595.69 - 605.18 |
| 52-week range | 492.84 - 654.62 |
| Volume | |
| Avg. volume | 79,293 |
| Market cap | 9.043B |
| Beta (5Y monthly) | 0.42 |
| PE ratio (TTM) | 33.30 |
| EPS (TTM) | 17.94 |
| Earnings date | 24 Apr 2024 |
| Forward dividend & yield | 1.60 (0.26%) |
| Ex-dividend date | 23 Feb 2024 |
| 1y target est | 690.00 |
ZacksHere's Why You Should Retain Chemed (CHE) Stock for Now
Investors are optimistic about Chemed (CHE), backed by the strong performance of the VITAS Healthcare and Roto-Rooter segments.
Business WireVITAS Completes the Previously Announced Purchase of Assets of Covenant in Florida and Alabama
CINCINNATI, April 17, 2024--VITAS Healthcare Corporation, a wholly-owned subsidiary of Chemed Corporation ("Chemed") (NYSE: CHE) announced the completion of the previously announced purchase of all hospice operations and an assisted living facility from Covenant Health and Community Services, Inc. d/b/a/ Covenant Care ("Covenant") for an aggregate purchase price of $85 million. The transaction is structured as an asset purchase.
ZacksAre You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
© 2024 Yahoo. All rights reserved.